MedTrace Logo

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

NCT00691678 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2022-11-08

Study results available
· View outcomes & findings →

Summary

Investigators are hoping to learn if glucosamine with chondroitin can help relieve joint pain/stiffness associated with aromatase inhibitors.

Conditions

Interventions

DRUG

Chondroitin

400mg chondroitin three times a day (TID) for twenty-four weeks

DRUG

Glucosamine

500mg glucosamine TID for twenty-four weeks

Sponsors & Collaborators

  • Dawn L. Hershman

    lead OTHER

Principal Investigators

  • Dawn Hershman, MD · Columbia University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-07-31
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00691678 on ClinicalTrials.gov